Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.
To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).
Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).
Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kalhori V et al. | Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1α in Thyroid Follicular Carcinoma Cells. | 2013 | PLoS ONE | pmid:23824493 |
Karimian G et al. | Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis. | 2013 | Biochim. Biophys. Acta | pmid:23816565 |
Tsai YC et al. | Antiapoptotic agent sphingosine-1-phosphate protects vitrified murine ovarian grafts. | 2014 | Reprod Sci | pmid:23793475 |
Schwalm S et al. | Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases. | 2014 | Basic Clin. Pharmacol. Toxicol. | pmid:23789924 |
Wang Y et al. | Epidermal growth factor receptor signaling-dependent calcium elevation in cumulus cells is required for NPR2 inhibition and meiotic resumption in mouse oocytes. | 2013 | Endocrinology | pmid:23787120 |
Zhang L et al. | Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P). | 2013 | Blood | pmid:23775711 |
Zhang W et al. | Sphingosine-1-phosphate receptor-2 mediated NFκB activation contributes to tumor necrosis factor-α induced VCAM-1 and ICAM-1 expression in endothelial cells. | 2013 | Prostaglandins Other Lipid Mediat. | pmid:23770055 |
O'Sullivan C and Dev KK | The structure and function of the S1P1 receptor. | 2013 | Trends Pharmacol. Sci. | pmid:23763867 |
Lee H et al. | 4-Deoxypyridoxine improves the viability of isolated pancreatic islets ex vivo. | 2013 May-Jun | Islets | pmid:23756681 |
Alberg AJ et al. | Plasma sphingolipids and lung cancer: a population-based, nested case-control study. | 2013 | Cancer Epidemiol. Biomarkers Prev. | pmid:23749868 |
Koch A et al. | Sphingosine 1-phosphate in renal diseases. | 2013 | Cell. Physiol. Biochem. | pmid:23736205 |
Guo L et al. | Sphingosine-1-phosphate inhibits ceramide-induced apoptosis during murine preimplantation embryonic development. | 2013 | Theriogenology | pmid:23731666 |
Tatematsu S et al. | Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. | 2013 | Arterioscler. Thromb. Vasc. Biol. | pmid:23723371 |
Fukuhara S and Mochizuki N | [Lymphocytes mobilization into blood regulated by Spns2, a sphingosine 1-phosphate transporter, expressed on endothelial cells]. | 2013 | Seikagaku | pmid:23717873 |
Willis MA and Cohen JA | Fingolimod therapy for multiple sclerosis. | 2013 | Semin Neurol | pmid:23709211 |
Bot M et al. | Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice. | 2013 | PLoS ONE | pmid:23700419 |
Lundblad C et al. | Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat. | 2013 | Acta Anaesthesiol Scand | pmid:23683126 |
Starzyńska T et al. | An intensified systemic trafficking of bone marrow-derived stem/progenitor cells in patients with pancreatic cancer. | 2013 | J. Cell. Mol. Med. | pmid:23672538 |
Usatyuk PV et al. | Coronin 1B regulates S1P-induced human lung endothelial cell chemotaxis: role of PLD2, protein kinase C and Rac1 signal transduction. | 2013 | PLoS ONE | pmid:23667561 |
Stradner MH et al. | Sphingosine 1-phosphate counteracts the effects of interleukin-1β in human chondrocytes. | 2013 | Arthritis Rheum. | pmid:23666803 |
Kurano M et al. | Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M. | 2013 | Atherosclerosis | pmid:23664237 |
Böhm A et al. | Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells. | 2013 | Cardiovasc. Res. | pmid:23658376 |
Egom EE et al. | HDL quality or cholesterol cargo: what really matters--spotlight on sphingosine-1-phosphate-rich HDL. | 2013 | Curr. Opin. Lipidol. | pmid:23652570 |
Christoffersen C and Nielsen LB | Apolipoprotein M: bridging HDL and endothelial function. | 2013 | Curr. Opin. Lipidol. | pmid:23652568 |
Cinq-Frais C et al. | A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1. | 2013 | Biochim. Biophys. Acta | pmid:23651497 |
Schaper K et al. | Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. | 2013 | J. Dermatol. Sci. | pmid:23643308 |
Hardin C et al. | Glassy dynamics, cell mechanics, and endothelial permeability. | 2013 | J Phys Chem B | pmid:23638866 |
Allende ML et al. | Sphingosine-1-phosphate phosphatase 1 regulates keratinocyte differentiation and epidermal homeostasis. | 2013 | J. Biol. Chem. | pmid:23637227 |
Orr Gandy KA et al. | Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation. | 2013 | FASEB J. | pmid:23629860 |
Schneider G et al. | Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy. | 2013 | Mol. Cancer Res. | pmid:23615526 |
Matsuzaki E et al. | Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. | 2013 | Bone | pmid:23612487 |
Salmanzadeh A et al. | Sphingolipid metabolites modulate dielectric characteristics of cells in a mouse ovarian cancer progression model. | 2013 | Integr Biol (Camb) | pmid:23609351 |
BÅ‚ogowski W et al. | Perioperative release of pro-regenerative biochemical signals from human renal allografts subjected to ischemia-reperfusion injury. | 2014 | Innate Immun | pmid:23608824 |
Wang Z et al. | Molecular basis of sphingosine kinase 1 substrate recognition and catalysis. | 2013 | Structure | pmid:23602659 |
Kroetsch JT and Bolz SS | The TNF-α/sphingosine-1-phosphate signaling axis drives myogenic responsiveness in heart failure. | 2013 | J. Vasc. Res. | pmid:23594703 |
Sobel K et al. | Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling. | 2013 | J. Biol. Chem. | pmid:23589284 |
Zu Heringdorf DM et al. | Pharmacology of the sphingosine-1-phosphate signalling system. | 2013 | Handb Exp Pharmacol | pmid:23579459 |
Nguyen DH et al. | Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. | 2013 | Proc. Natl. Acad. Sci. U.S.A. | pmid:23569284 |
Kikuta J et al. | Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D. | 2013 | Proc. Natl. Acad. Sci. U.S.A. | pmid:23569273 |
Vessey DA et al. | FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning. | 2013 | Med Sci Monit Basic Res | pmid:23567658 |
Bruni P and Donati C | Role of sphingosine 1-phosphate in skeletal muscle cell biology. | 2013 | Handb Exp Pharmacol | pmid:23563671 |
Gandy KA and Obeid LM | Regulation of the sphingosine kinase/sphingosine 1-phosphate pathway. | 2013 | Handb Exp Pharmacol | pmid:23563662 |
Abbasi T and Garcia JG | Sphingolipids in lung endothelial biology and regulation of vascular integrity. | 2013 | Handb Exp Pharmacol | pmid:23563658 |
Levkau B | Cardiovascular effects of sphingosine-1-phosphate (S1P). | 2013 | Handb Exp Pharmacol | pmid:23563656 |
Jiang XC and Liu J | Sphingolipid metabolism and atherosclerosis. | 2013 | Handb Exp Pharmacol | pmid:23563655 |
Pyne S and Pyne NJ | New perspectives on the role of sphingosine 1-phosphate in cancer. | 2013 | Handb Exp Pharmacol | pmid:23563651 |
Selvam SP and Ogretmen B | Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance. | 2013 | Handb Exp Pharmacol | pmid:23563649 |
Bernhart E et al. | Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro. | 2013 | Exp. Cell Res. | pmid:23562655 |
Guo H et al. | An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway. | 2013 | J. Neurosci. | pmid:23554499 |
Goyal P et al. | Cytokine IL-6 secretion by trophoblasts regulated via sphingosine-1-phosphate receptor 2 involving Rho/Rho-kinase and Rac1 signaling pathways. | 2013 | Mol. Hum. Reprod. | pmid:23538947 |
Morozov VI et al. | Sphingosine-1-phosphate: distribution, metabolism and role in the regulation of cellular functions. | 2013 Jan-Feb | Ukr Biokhim Zh (1999) | pmid:23534286 |
Matheu MP et al. | Three phases of CD8 T cell response in the lung following H1N1 influenza infection and sphingosine 1 phosphate agonist therapy. | 2013 | PLoS ONE | pmid:23533579 |
Arce FT et al. | Heterogeneous elastic response of human lung microvascular endothelial cells to barrier modulating stimuli. | 2013 | Nanomedicine | pmid:23523769 |
Wallington-Beddoe CT et al. | Oncogenic properties of sphingosine kinases in haematological malignancies. | 2013 | Br. J. Haematol. | pmid:23521541 |
Yonesu K and Nara F | [Anti-angiogenic effect of bioactive lipid antagonists]. | 2012 | Nippon Rinsho | pmid:23513926 |
Barth BM et al. | Gaucher's disease and cancer: a sphingolipid perspective. | 2013 | Crit Rev Oncog | pmid:23510065 |
Bendall LJ and Basnett J | Role of sphingosine 1-phosphate in trafficking and mobilization of hematopoietic stem cells. | 2013 | Curr. Opin. Hematol. | pmid:23507960 |
Loetscher E et al. | Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors. | 2013 | Biochem. Biophys. Res. Commun. | pmid:23499842 |
Tran-Dinh A et al. | HDL and endothelial protection. | 2013 | Br. J. Pharmacol. | pmid:23488589 |
Yang L et al. | Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis. | 2013 | J. Hepatol. | pmid:23466305 |
Erkhembaatar LO et al. | Increased expression of sphingosine kinase in the amnion during labor. | 2013 | Placenta | pmid:23462226 |
Natarajan V et al. | Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. | 2013 | Am. J. Respir. Cell Mol. Biol. | pmid:23449739 |
Reichardt P et al. | A role for LFA-1 in delaying T-lymphocyte egress from lymph nodes. | 2013 | EMBO J. | pmid:23443048 |
Gaveglio VL et al. | Phosphatidic acid metabolism in rat liver cell nuclei. | 2013 | FEBS Lett. | pmid:23439070 |
Kusch A et al. | Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury. | 2013 | Acta Physiol (Oxf) | pmid:23432924 |
Kawahara S et al. | Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells. | 2013 | Anticancer Drugs | pmid:23426175 |
Camacho L et al. | Acid ceramidase as a therapeutic target in metastatic prostate cancer. | 2013 | J. Lipid Res. | pmid:23423838 |
Mudd JC et al. | Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes. | 2013 | Blood | pmid:23422746 |
Ono Y et al. | Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration. | 2013 | Lipids Health Dis | pmid:23418753 |
Dusaban SS et al. | Phospholipase C epsilon links G protein-coupled receptor activation to inflammatory astrocytic responses. | 2013 | Proc. Natl. Acad. Sci. U.S.A. | pmid:23401561 |
Southern C et al. | Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. | 2013 | J Biomol Screen | pmid:23396314 |
CamprubÃ-Robles M et al. | Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor. | 2013 | J. Neurosci. | pmid:23392686 |
Yangyuoru PM et al. | Fluorescent lipids as probes for sphingosine kinase activity by capillary electrophoresis. | 2013 | Methods Mol. Biol. | pmid:23386355 |
Lee YJ et al. | Sphingosine-1-phosphate protects against bisphosphonate‑induced HUVEC cell death via regulation of c-Jun‑N‑terminal kinase signaling. | 2013 | Int. J. Mol. Med. | pmid:23381659 |
Chang CH et al. | Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro. | 2013 | Acta Pharmacol. Sin. | pmid:23377549 |
Salata D et al. | [Sphingosine-1-phosphate--molecular maestro]. | 2012 | Postepy Biochem. | pmid:23373414 |
Finley A et al. | Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism. | 2013 | PLoS ONE | pmid:23372844 |
Babahosseini H et al. | Roles of bioactive sphingolipid metabolites in ovarian cancer cell biomechanics. | 2012 | Conf Proc IEEE Eng Med Biol Soc | pmid:23366417 |
Tong X et al. | High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate. | 2013 | Cardiovasc Diabetol | pmid:23360427 |
Dillahunt SE et al. | Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined. | 2013 | J. Immunol. | pmid:23359503 |
Sharma N et al. | Sphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cells. | 2013 | J. Leukoc. Biol. | pmid:23345392 |
Cortez-Retamozo V et al. | Angiotensin II drives the production of tumor-promoting macrophages. | 2013 | Immunity | pmid:23333075 |
Yasuo M et al. | Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate. | 2013 | PLoS ONE | pmid:23326540 |
Lotinun S et al. | Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. | 2013 | J. Clin. Invest. | pmid:23321671 |
Tibolla G et al. | Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis. | 2013 | PLoS ONE | pmid:23320105 |
Salvemini D et al. | Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain. | 2013 | Trends Pharmacol. Sci. | pmid:23318139 |
Huang LS et al. | Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. | 2013 | FASEB J. | pmid:23315259 |
Watson DG et al. | The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells. | 2013 | Cell. Signal. | pmid:23314175 |
Kim YD et al. | Effects of sphingosine-1-phosphate on pacemaker activity of interstitial cells of Cajal from mouse small intestine. | 2013 | Mol. Cells | pmid:23307289 |
Osawa Y et al. | Liver acid sphingomyelinase inhibits growth of metastatic colon cancer. | 2013 | J. Clin. Invest. | pmid:23298833 |
Heffernan-Stroud LA and Obeid LM | Sphingosine kinase 1 in cancer. | 2013 | Adv. Cancer Res. | pmid:23290781 |
Alshaker H et al. | Therapeutic potential of targeting SK1 in human cancers. | 2013 | Adv. Cancer Res. | pmid:23290780 |
Cuvillier O et al. | Hypoxia, therapeutic resistance, and sphingosine 1-phosphate. | 2013 | Adv. Cancer Res. | pmid:23290779 |
Karapetyan AV et al. | Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction. | 2013 | Stem Cells Dev. | pmid:23282236 |
Liang J et al. | Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. | 2013 | Cancer Cell | pmid:23273921 |
Kleinjan A et al. | Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model. | 2013 | Allergy | pmid:23253209 |
Billich A et al. | Cellular assay for the characterization of sphingosine-1-phosphate lyase inhibitors. | 2013 | Anal. Biochem. | pmid:23246729 |
Evindar G et al. | Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1. | 2013 | Bioorg. Med. Chem. Lett. | pmid:23245510 |
Xu Y et al. | Low sphingosine-1-phosphate impairs lung dendritic cells in cystic fibrosis. | 2013 | Am. J. Respir. Cell Mol. Biol. | pmid:23239501 |
Park K et al. | A novel role of a lipid species, sphingosine-1-phosphate, in epithelial innate immunity. | 2013 | Mol. Cell. Biol. | pmid:23230267 |